Search results
2 Soaring Stocks I'd Buy Now With No Hesitation
The Motley Fool via AOL· 10 hours ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from...
3 Magnificent Stocks Warren Buffett Can't Stop Buying
Motley Fool via Yahoo Finance· 1 day ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance...
Box Office: ‘Bad Boys: Ride or Die’ Buddies Up to $21.6 Million Opening Day
Variety· 3 hours agoThe boys are back in town. The action sequel, directed by Adil El Arbi and Bilall Fallah, is now...
3 Top Growth Stocks to Buy in June
Motley Fool via Yahoo Finance· 7 hours ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from...
Coronavirus updates: Another 4.4 million US jobless claims, CDC director warns of second wave
CNET· 2 days agoThe coronavirus pandemic has upended life across the globe. Health care systems are scrambling to...
Reading officials share progress on effort to improve health literacy
Reading Eagle, Pa. via Yahoo News· 4 days agoEddie Moran knows a thing or two about health care. Before he was elected mayor of Reading, Moran was a health insurance agent who would often visit individuals in their homes to enroll them ...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 2 days agoLast September, the FDA approved updated boosters from Pfizer and Moderna, but didn't authorize...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
The Kansas City Star· 1 day agoManufacturing is underway and doses of Moderna’s Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval
2 Growth Stocks That Are Screaming Buys in June
Motley Fool via Yahoo Finance· 2 days agoAmazon is investing heavily in AWS' AI capabilities by building new data centers worldwide, launching new AI tools, and venturing into chip production....
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for...
Morningstar· 4 days agoThe Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387, when given as a slow bolus intravenous infusion, resulted in a relatively flat plateau of blood ...
